Tango Therapeutics stock fell after announcing a $210 million equity offering priced at $8.66 per share, raising funds from major investors like Farallon Capital and T. Rowe Price.The post Tango Therapeutics Stock Falls After $210 Million Equity Offering appeared first on Tokenist.